- heart attack,
- pulmonary embolism,
- deep vein thrombosis
- blood clots
- Blood clots
- Deep vein thrombosis
- Heart attack
- Pulmonary embolism
Yaz Manufactured by Bayer Pharmaceuticals was one of the most popular birth control pills. Unfortunately due to the ingredients has been shown to cause blood clots, pulmonary embolism, blood clots, stroke, deep vein thrombosis and in some cases fatal complications.
The Yaz Birth Control Pills Helpline is launching a nationwide campaign to locate women who suffered a blood clot after taking the birth control pill Yaz. There are state statute of limitations in effect and time may be limited to file your Yaz lawsuit.
I you, a daughter, wife, sister or friend has suffered a blood clot, Deep Vein Thrombosis, stroke or Pulmonary Embolism after taking Yaz or Yasmin contact the Yaz Birth Control Pills Helpline to be connected with a Yaz lawyer to see if you have a Yaz lawsuit. The first payouts for Yaz blood clots have begun, The Yaz Birth Control Pills Helpline does not want any woman injured by Yaz to be left pour or find out it is too late.
On October 25, 2011, the British Medical Journal published a study from the University of Copenhagen linking the hormone in Yaz to blood clots. On October 27, 2011, the FDA released its own study entitled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" showing drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.
On May 31, 2012, the QuarterWatch report from the Institute for Safe Medicine Practices ranked Yaz and Yasmin second highest in 2011 for the number of complications reported to the FDA.
A Yaz Multi-District Litigation has been assignned in Illinois to consolidate these cases. The legal term for the Yaz lawsuits is Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois). More than 10,000 women have filed a Yaz blood clot claim.
Bayer has now begun settlle Yaz lawsuits with the first payouts at an average of $212,000 for each injured claimant. Bayer has set aside up to $610 million to settle the Yaz blood clot lawsuits. If you have a blood clot resulting in pulmonary embolism, deep vein thrombosis, or stroke from Yaz now would be the time to file your Yaz lawsuit claim if you have not done so. Time is limited for anyone with resulting blood clots, stroke, Deep Vein Thrombosis or pulmonary embolism after taking Yaz.
The Yaz Bitrth Control Pills Helpline Outreach will begin with the major and most populated cities in the U.S. to reach out to women injured by Yaz and connect them to a n experienced drug litigation, mass tort lawyer.
An initial outreach to locate women with blood clots from Yaz will be in New York, Los Angeles, Chicago, Houston, Philadelphia, Phoenix, San Antonio, San Diego, Dallas, and San Jose,
The next will include:Jacksonville, Indianapolis, San Francisco, Austin, Columbus, Fort Worth, Charlotte, Detroit, and El Paso,and continue continue to Baltimore, Boston, Seattle, Washington, DC, Denver, Milwaukee, Portland and, Las Vegas,
Women who have been injured with Blood Clots by Yaz will also be introduced to the Yaz Birth Control Pills Helpline in Oklahoma City, Albuquerque, Tucson, Fresno, Sacramento, Long Beach, Kansas City, Mesa, Virginia Beach, Atlanta, Colorado Springs, Omaha, Raleigh, Miami, Cleveland, Tulsa, Oakland, Minneapolis, Wichita, and Arlington,
Ohio Yaz lawyers filing lawsuits for Pulmonary Embolism , Stroke and blood clots from yaz. Bayers settlements for the blood clots injury and death are currently underway. I thought the following Yaz Ohio Report Noteworthy:
« Yaz Lawyers Allege That Yaz and Yasmin Are Not Safe Or Effective | Main | »
Plaintiff Suffered Pulmonary Embolism After Using Yaz
The Ohio lawsuit of Beck v. Bayer alleges that the embolism was caused by Yaz:
Yasmin, (a predecessor to YAZ), known generically as drospirenone and ethinyl estradiol, is a combination birth control pill originally developed by Defendant BERLEX LABORATORIES, INC. and/or Defendant BERLEX, INC containing the hormones estrogen and progestin.The estrogen is ethinyl estradiol and the progestin is drospirenone, (3 mg of drospirenone and 0.03 mg of ethinyl estradiol per tablet) Combination birth control pills are referred to as combined hormonal oral contraceptivesYasmin was approved by the FDA in April, 2001In 2006, Bayer acquired Defendant BERLEX LABORATORIES, INC. and/or Defendant BERLEX, INC, and began marketing an almost identical drug, YAZ (which contains 3 mg of drospirenone and 0.02 mg of ethinyl estradiol per tablet). The difference between YAZ/Yasmin and other birth control pills on the market is that drospirenone has never before been marketed in the United States and is unlike other progestins available in the United States.In April 2002, the British Medical Journal reported that the Dutch College of General Practitioners recommended that older second generation birth control pills be prescribed in lieu of Yasmin as a result of 40 cases of venous thrombosis among women taking Yasmin. In February 2003, a paper entitled Thromboembolism Associated With the New Contraceptive Yasmin was published in the British Medical Journal detailing a Netherlands Pharmacovigilance Centre report of five additional reports of thromboembolism where Yasmin was suspected as the cause, including two deaths.Defendants have been warned at least three times by the FDA; in 2003, 2008 and 2009, for misleading the public through the use of ads which overstate the efficacy of YAZ and/or its predecessor Yasmin, and minimize serious risks associated with the drug. The use of YAZ has a prothrombotic effect resulting in thrombosis such as the pulmonary embolism suffered by Plaintiff. Defendants ignored the correlation between the use of YAZ and increased thrombosis formation despite the wealth of scientific information available.
Yaz lawyers are filing lawsuits for Yaz Pulmonary embolism and blood clots.
Columbus, Cleveland, Cincinnati, Toledo, Akron, Dayton, Parma, Canton, Youngstown , Lorain Ohio are seeing many cases with fatalities in young women from yaz blood clots.
A 2009 study published in Contraception explains how Yaz may increase the risk of pulmonary embolism and other cardiovascular injuries, because pills with the chemical combination of drospirenone (progestin) and ethinylestradiol (estrogen) cause an increase in lipid peroxidation. This leads to high levels of serum copper, a situation that increases the risk of cardiovascular injury, such as
Blood clots. Blood clots anyplace in the body can be dangerous but, in the brain or lungs can be fatal.